anti-Peptidyl Arginine Deiminase, Type IV (PADI4) Antibodies

PADI4 is a member of a gene family which encodes enzymes responsible for the conversion of arginine residues to citrulline residues. Additionally we are shipping PADI4 Kits (14) and PADI4 Proteins (13) and many more products for this protein.

list all antibodies Gene Name GeneID UniProt
PADI4 23569 Q9UM07
PADI4 18602 Q9Z183
PADI4 29512 O88807
How to order from antibodies-online
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Order online
  • orders@antibodies-online.com

Top anti-PADI4 Antibodies at antibodies-online.com

Showing 10 out of 109 products:

Catalog No. Reactivity Host Conjugate Application Images Quantity Supplier Delivery Price Details
Cow Rabbit Un-conjugated WB Host: Rabbit Target Name: PADI4 Sample Type: 721_B Cell lysates Antibody Dilution: 1.0ug/ml  There is BioGPS gene expression data showing that PADI4 is expressed in 721_B 100 μL Log in to see 2 to 3 Days
$289.00
Details
Human Rabbit Un-conjugated EIA, WB 0.4 mL Log in to see 6 to 8 Days
$390.50
Details
Human Rabbit Un-conjugated WB Western blot analysis of anti-PAD4 Pab (ABIN389125) in 293 cell line lysate. PAD4(arrow) was detected using the purified polyclonal antibody. 400 μL Log in to see 10 to 11 Days
$324.50
Details
Human Goat Un-conjugated ELISA, WB ABIN185308 (0.3µg/ml) staining of human spleen lysate (35µg protein in RIPA buffer). Primary incubation was 1 hour. Detected by chemiluminescence. 100 μg Log in to see 6 to 7 Days
$326.89
Details
Bat Rabbit Un-conjugated WB 50 μg Log in to see 7 to 9 Days
$551.83
Details
Human Mouse Un-conjugated IF, IHC (p), WB 100 μL Log in to see 7 to 9 Days
$493.17
Details
Human Mouse Un-conjugated IHC (p), WB 100 μL Log in to see 7 to 9 Days
$493.17
Details
Human Mouse Un-conjugated FACS, IF, IHC (p), WB 100 μL Log in to see 7 to 9 Days
$493.17
Details
Human Mouse Un-conjugated FACS, WB 100 μL Log in to see 7 to 9 Days
$493.17
Details
Human Rabbit Un-conjugated WB Anti-PADI4/PAD4 antibody, Western blotting Lane 1: PANC Cell Lysate Lane 2: 293T Cell Lysate 100 μg Log in to see 4 to 6 Days
$200.00
Details

PADI4 Antibodies by Reactivity, Application, Clonality and Conjugate

Attributes Applications Host Clonality Conjugate
Human , , , ,
, ,
,
, , , , , , , , , , , , , , , ,
Mouse (Murine) , ,


,
Rat (Rattus) ,


Top referenced anti-PADI4 Antibodies

  1. Human Polyclonal PADI4 Primary Antibody for ELISA, WB - ABIN250318 : Wang, Wysocka, Sayegh, Lee, Perlin, Leonelli, Sonbuchner, McDonald, Cook, Dou, Roeder, Clarke, Stallcup, Allis, Coonrod: Human PAD4 regulates histone arginine methylation levels via demethylimination. in Science (New York, N.Y.) 2004 (PubMed)
    Show all 2 Pubmed References

  2. Cow (Bovine) Polyclonal PADI4 Primary Antibody for WB - ABIN2785937 : Costenbader, Chang, De Vivo, Plenge, Karlson: Genetic polymorphisms in PTPN22, PADI-4, and CTLA-4 and risk for rheumatoid arthritis in two longitudinal cohort studies: evidence of gene-environment interactions with heavy cigarette smoking. in Arthritis research & therapy 2008 (PubMed)

More Antibodies against PADI4 Interaction Partners

Human Peptidyl Arginine Deiminase, Type IV (PADI4) interaction partners

  1. PADI4 contributes to the pathogenesis of RA by protecting FLSs from apoptosis. PADI4 suppresses p21 (show CDKN1A Antibodies) transcription through altering histone H3 (show HIST3H3 Antibodies) arginine modifications on p21 (show CDKN1A Antibodies) promoter region.

  2. Proteolysis by granzyme B (show Gzmb Antibodies) enhances presentation of autoantigenic PAD4 epitopes in rheumatoid arthritis.

  3. No associations were found between clinical subtypes of JIA and PADI4 allele frequency. rs2240337 in the PADI4 gene was significantly associated with anti-cyclic citrullinated peptide antibody-positivity in juvenile idiopathic arthritis.

  4. The effect of the PADI4-104C/T polymorphism on RA risk in the Chinese population was evaluated in a meta-analysis. The overall analysis indicated a significant association between the PADI4-104C/T polymorphism and RA risk in the Chinese population (T vs C: OR = 1.45, 95%CI = 1.18-1.78; TT vs CC: OR = 1.49, 95%CI = 1.24-1.80; TT vs CC+CT: OR = 1.28, 95%CI = 1.08-1.51; TT+CT vs CC: OR = 1.75, 95%CI = 1.30-2.37).

  5. Overexpression of PAD4 constrains the activity of EMT (show ITK Antibodies) via suppressing Elk1 (show ELK1 Antibodies) expression.

  6. Our study also demonstrated that PADI4 contributes to tumor metastasis by regulating the gene expression of insulin-like growth factor 1 (IGF1 (show IGF1 Antibodies)) and WAS/WASL-interacting protein family member 1 (WIPF1 (show WIPF1 Antibodies)).

  7. PAD4 levels were significantly higher in patients with rheumatoid arthritis than in patients with systemic lupus erythematosis or healthy controls. Anti-PAD4 antibodies were detected in 30% of patients with rheumatoid arthritis, but not in patients with SLE, systemic sclerosis or controls.

  8. This meta-analysis showed that the PADI4 -94G/A variants may influence RA risk in the Chinese population.

  9. The results highlight an association between PAD4 and DNA hypermethylation in acute promyelocytic leukemia (show PML Antibodies) and demonstrate that targeting PAD4 or regulating its downstream effectors may be a promising strategy to control differentiation in the clinic.

  10. We identified the presence of PADI3 (show PADI3 Antibodies) mRNA expression in synovial tissue and PADI2 (show PADI2 Antibodies) and PADI4 mRNA expressions in fibroblast-like synoviocytes from patients with rheumatoid arthritis.

Mouse (Murine) Peptidyl Arginine Deiminase, Type IV (PADI4) interaction partners

  1. sFlt-1 overexpression in Padi4(-/-) mice resulted in dramatically lower inflammatory and thrombotic response, which was accompanied by significant reduction in pregnancy losses. Inhibition of NETosis may serve as a novel target in disorders of impaired placentation.

  2. a role for NETs in cardiac fibrosis and conclude that PAD4 regulates age-related organ fibrosis and dysfunction.

  3. PADI4 exacerbates arthritis with diverse immunological modifications.

  4. Selective inhibition of peptidylarginine deiminase IV with Cl-amidine blocked NET formation, reduced atherosclerotic lesion area, and delayed time to carotid artery thrombosis in a photochemical injury model.

  5. Padi4 is part of the pluripotency transcriptional network, binding to regulatory elements of key stem-cell genes and activating their expression

  6. PAD4 regulates the proliferation of multipotent progenitors in the bone marrow by controlling c-myc (show MYC Antibodies) expression.

  7. PAD4-mediated chromatin decondensation in the neutrophil is crucial for pathological venous thrombosis and present neutrophil activation and PAD4 as potential drug targets for deep vein thrombosis.

  8. PAD4 is dispensable in this effector phase model of arthritis

  9. analysis of regulation of histone modification and chromatin structure by the p53 (show TP53 Antibodies)-PADI4 pathway

  10. An increase in citrullinated proteins resulting from increased PAD2 and 4 is an important change in the pathogenesis of multiple sclerosis.

PADI4 Antigen Profile

Protein Summary

This gene is a member of a gene family which encodes enzymes responsible for the conversion of arginine residues to citrulline residues. This gene may play a role in granulocyte and macrophage development leading to inflammation and immune response.

Gene names and symbols associated with PADI4

  • peptidyl arginine deiminase, type IV (PADI4) antibody
  • peptidyl arginine deiminase, type IV (Padi4) antibody
  • PAD antibody
  • Pad4 antibody
  • PADI5 antibody
  • Pdi4 antibody
  • PDI5 antibody

Protein level used designations for PADI4

peptidyl arginine deiminase, type IV , protein-arginine deiminase type-4-like , HL-60 PAD , PADI-H protein , peptidyl arginine deiminase, type V , protein-arginine deiminase type IV , protein-arginine deiminase type-4 , PAD type IV , peptidylarginine deiminase IV , PAD-R4 , peptidyl arginine deiminase, type 4 , peptidylarginine deiminase type alpha

GENE ID SPECIES
100026011 Monodelphis domestica
100049826 Equus caballus
100415489 Callithrix jacchus
100471129 Ailuropoda melanoleuca
100592291 Nomascus leucogenys
23569 Homo sapiens
18602 Mus musculus
456530 Pan troglodytes
29512 Rattus norvegicus
606921 Canis lupus familiaris
508161 Bos taurus
100524749 Sus scrofa
Selected quality suppliers for anti-PADI4 (PADI4) Antibodies
Did you look for something else?